April 2024 FDA Recall Drug by Stop Clopez Corp
D-0494-2024 - Marketed Without An Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Stop Clopez Corp on April 22, 2024 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed in Distribution worldwide via amazon.com and the recall is currently terminated.

Recall Number: D-0494-2024

Reason for Recall
Marketed Without An Approved NDA/ANDA
Initiated
04-22-2024
Reported
05-22-2024
Quantity
5 boxes

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
94455
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Stop Clopez Corp
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
N/A
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Distribution worldwide via amazon.com
Termination Date About Termination Date
Date that FDA officially terminated the recall.
04-08-2025
Product Description About Product Description
Full technical description of the product.
Schwinnng Herbal Dietary Supplement Capsules, packaged in 10-count boxes, distributed by VSD Productions Inc., Las Vegas, NV.

Batch or Lot Expiration Information

Lot# Lot 2108; EXP 10/31/2024